Pliant Therapeutics (PLRX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Pliant Therapeutics (PLRX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Pliant Therapeutics

· PLRX

Dashboard

Financials

Ratios

Valuation

Statistics

66.876 M

+0.00%

General

Market Cap: $66.88M
Enterprise Value: $70.73M
Shares Outstanding: 61,920,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -48.60%
ROE: -53.22%
ROIC: -55.49%
Current Ratio: 9.90
Debt-to-Equity: 0.20
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 0.46
EV/EBITDA: -0.80

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $97.22M
Operating Income: -$97.48M
Net Profit: -$92.29M

Balance Sheet

Cash and Equivalents: $24.88M
Working Capital: $146.66M
Total Assets: $189.88M
Net Debt: $3.86M
Total Liabilities: $42.96M
Total Equity: $146.93M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$70.9M
Cash Flow from Investing: $41.08M
Cash Flow from Financing: -$32.12M
Free Cash Flow: -$70.9M
Capital Expenditures: $0